top of page
Profile
Join date: Jun 2, 2023
Posts (10)
Apr 15, 2024 ∙ 3 min
20MED THERAPEUTICS PUBLISHES POSITIVE IN VIVO EFFICACY DATA OF A MRNA INFLUENZA VACCINE USING ITS PROPRIETARY POLYMERIC NANOPARTICLE TECHNOLOGY
Preclinical data underscores the potential to deliver a strong protective effect using Polymeric Nanoparticles (PNPs), an alternative to...
562
0
Apr 13, 2024 ∙ 1 min
Come and meet us at BIO2024
Meet the 20Med Therapeutics team in San Diego during the BIO International Convention to discuss partnering opportunities around our PNP...
317
0
Nov 28, 2023 ∙ 2 min
20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer
Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the...
402
0
voorhoeve1
Admin
More actions
bottom of page